देश: स्लोवेनिया
भाषा: अंग्रेज़ी
स्रोत: HMA (Heads of Medicines Agencies)
enrofloxacin 50 mg/ml
aniMedica GmbH
QJ01MA90
Solution for injection
enrofloxacin
Cattle Food, Dogs Non Food, Pigs Food
2012-07-25
1 von 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 50, 50 mg/ml solution for injection for cattle (calves), pigs and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE Enrofloxacin 50.0 mg EXCIPIENTS 1-Butanol 30.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, slightly yellowish to yellowish orange solution. 4. CLINICAL PARTICULARS 4.1 TARGE T SPECIES Cattle (Calves) Pigs Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of infectious diseases in calves, pigs and dogs caused by the following enrofloxacin- susceptible gram-negative and gram-positive bacteria and mycoplasma: _ _ CATTLE (CALVES): - Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia) and secondary bacterial infections subsequent to viral infections (e.g. "crowding disease"). - _E. coli, Haemophilus _spp_., Pasteurella _spp_., Mycoplasma bovis_ PIGS: - Diseases of the respiratory (enzootic pneumonia, pleuropneumonia) and alimentary tract (colidiarrhoea, colisepticemia) of bacterial or mycoplasmal origin, MMA-syndrome of sows - _E. coli, Pasteurella spp., Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae. _ _ _ DOGS: - Treatment of bacterial single and mixed infections of the alimentary, respiratory and urogenital tracts, skin and wound infections. - _E. coli, Salmonella spp., Pasteurella spp., Haemophilus spp., Staphylococci. _ _ _ Enrofloxacin should be u पूरा दस्तावेज़ पढ़ें